GO:1904628 cellular response to phorbol 13-acetate 12-mystate: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904628 describes the cellular response to phorbol 13-acetate 12-myristate (PMA), a potent tumor promoter and protein kinase C (PKC) activator [1, 2].
• PMA is widely used to differentiate monocytic cell lines such as THP-1 and U937 into macrophage-like cells, a model for studying inflammation and immune responses [1, 2, 3].
• The response involves rapid activation of PKC, leading to downstream signaling cascades that alter gene expression, cytokine production, and cellular metabolism [4, 6].
• PMA treatment induces specific transcriptional programs, including upregulation of Oncostatin-M and modulation of immune-related genes [4, 6].
• Dysregulation of PMA-responsive pathways is implicated in cancer, inflammatory diseases, and immune disorders [7, 8].
• CRISPR-based models (knockout, knock-in, overexpression) enable precise dissection of genes involved in the PMA response for drug discovery and disease research.
Description
The Gene Ontology (GO) term GO:1904628, cellular response to phorbol 13-acetate 12-myristate, defines the cellular processes triggered by exposure to phorbol 13-acetate 12-myristate (PMA), also known as phorbol 12-myristate 13-acetate (PMA) or tetradecanoylphorbol acetate (TPA) [1, 2]. PMA is a diterpene phorbol ester that acts as a potent tumor promoter and a classic activator of protein kinase C (PKC) [5, 8]. Because of its ability to mimic diacylglycerol (DAG), PMA binds to and activates PKC isoforms, initiating a cascade of phosphorylation events that regulate diverse cellular functions, including proliferation, differentiation, apoptosis, and immune responses [5, 8]. Researchers use PMA extensively to study signal transduction, macrophage differentiation, and inflammatory pathways [1, 2, 3]. The term GO:1904628 captures the sum of these cellular changes, providing a framework to annotate genes and pathways responsive to PMA. Understanding this response is critical for modeling diseases such as cancer and chronic inflammation, and for developing targeted therapies [7, 8].
cellular response to phorbol 13-acetate 12-myristate At A Glance
| GO ID | GO:1904628 |
|---|---|
| GO term | cellular response to phorbol 13-acetate 12-myristate |
| Ontology | biological_process |
| Synonym | cellular response to phorbol 12-tetradecanoate 13-acetate; cellular response to PMA; cellular response to tetradecanoylphorbol acetate; cellular response to TPA |
| Major function | Mediates cellular responses to PMA, including PKC activation, differentiation, cytokine production, and gene expression changes |
| Related stimuli | Phorbol esters, DAG analogs |
| Key pathways | PKC signaling, MAPK cascade, NF-κB activation |
| Cell types | Monocytes, macrophages, melanoma cells, astrocytic tumor cells, myoblasts |
What Is GO:1904628?
GO:1904628 is a biological process term that encompasses any change in a cell's state or activity (e.g., movement, secretion, enzyme production, gene expression) resulting from a stimulus of phorbol 13-acetate 12-myristate. This includes the immediate signaling events following PKC activation and the subsequent transcriptional and phenotypic alterations that define the cellular response to PMA [1, 2, 4].
Why Is cellular response to phorbol 13-acetate 12-myristate Important in Cell Biology?
GO:1904628 is important because PMA is a ubiquitous tool in biomedical research, used to induce differentiation, activate immune cells, and study signal transduction [1, 2, 3]. The cellular response to PMA mirrors key aspects of physiological and pathological processes, such as inflammation, cancer progression, and immune cell activation [4, 6, 7]. By understanding this response, researchers can identify therapeutic targets and biomarkers for diseases like leukemia, melanoma, and inflammatory disorders [7, 8].
• PMA is a standard agent for differentiating monocytic cell lines (THP-1, U937) into macrophages, a model for studying innate immunity and inflammation [1, 2, 3].
• The response involves activation of PKC isoforms, which are critical regulators of cell growth, differentiation, and apoptosis [5, 8].
• PMA-induced signaling modulates the expression of cytokines and growth factors, such as Oncostatin-M, impacting immune cell communication.
• Dysregulated PMA-responsive pathways contribute to cancer development, including melanoma and astrocytic tumors [7, 8].
• PMA treatment is used to study NLRP3 inflammasome activation and IL-1β secretion, relevant to autoinflammatory diseases.
• Proteomic and transcriptomic analyses of PMA-treated cells reveal global changes in immune responses and metabolism.
• The term helps annotate genes and pathways in GO, facilitating functional genomics and systems biology studies.
• CRISPR screens targeting PMA-responsive genes can uncover novel regulators of differentiation and inflammation.
• PMA is a tumor promoter in experimental carcinogenesis models, linking the response to cancer biology.
• Understanding PMA response aids in optimizing differentiation protocols for cell-based therapies and disease modeling [1, 2].
What Happens During cellular response to phorbol 13-acetate 12-myristate?
PKC Activation and Early Signaling
In simple terms: PMA acts like a key that turns on PKC enzymes, which then start a chain of signals inside the cell.
PMA binds to the C1 domain of protein kinase C (PKC) isoforms, mimicking diacylglycerol (DAG) and leading to PKC activation [5, 8]. This activation causes PKC to translocate to membranes and phosphorylate downstream targets, initiating signaling cascades such as the MAPK/ERK pathway. In myoblasts, PMA binding was shown to be specific and saturable, indicating receptor-mediated effects. The immediate response includes changes in ion fluxes, second messenger production, and activation of transcription factors like NF-κB and AP-1 [4, 6].
Transcriptional Reprogramming
In simple terms: The cell changes which genes are turned on or off, leading to new proteins and functions.
PMA stimulation leads to altered expression of numerous genes involved in immune response, cell cycle, and differentiation [4, 6]. For example, PMA induces the transcription of Oncostatin-M, a cytokine that regulates inflammation and cell growth. Comparative proteomic analysis of THP-1 monocytes treated with PMA revealed dynamic changes in proteins related to immune responses, including upregulation of macrophage markers and downregulation of monocyte markers. These transcriptional changes are mediated by activated PKC and downstream kinases that phosphorylate transcription factors [4, 8].
Differentiation and Morphological Changes
In simple terms: Cells like monocytes transform into macrophage-like cells, changing shape and function.
PMA treatment of monocytic cell lines (THP-1, U937) induces differentiation into macrophage-like cells, characterized by adherence, spreading, and expression of macrophage-specific surface markers [1, 2, 3]. The choice of PMA differentiation protocol (concentration, duration, resting time) significantly influences the resulting macrophage phenotype and their response to pro-inflammatory stimuli [1, 2]. For instance, resting time after PMA treatment affects NLRP3 inflammasome activation and IL-1β secretion. Synergism between PMA and vitamin D3 enhances differentiation of U937 cells to monocytes/macrophages.
Functional Consequences: Cytokine Secretion and Immune Modulation
In simple terms: The cell releases signals that affect the immune system and other cells.
PMA-induced differentiation and activation lead to secretion of cytokines and chemokines, such as TNF-α, IL-1β, and Oncostatin-M [2, 4]. In melanoma cells, PMA induces resistance to natural killer (NK) and lymphokine-activated killer (LAK) cell-mediated cytotoxicity, suggesting a role in immune evasion. In astrocytic tumor cells, PMA induces a PKC-eta-specific proliferative response, highlighting cell-type-specific outcomes. These functional changes are critical for modeling inflammatory diseases and cancer [7, 8].
Negative Feedback and Termination
In simple terms: The cell has ways to shut down the response to avoid overactivation.
Prolonged PMA exposure can lead to downregulation of PKC isoforms, desensitizing the cell to further stimulation. Negative feedback mechanisms, including phosphatases and degradation of signaling intermediates, help terminate the response. Understanding these regulatory loops is essential for interpreting experimental outcomes and for designing therapeutic interventions [6, 8].
Key Genes Involved in GO:1904628 cellular response to phorbol 13-acetate 12-myristate
The following genes and proteins are central to the cellular response to PMA, as evidenced by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKCA | PKC alpha isoform; mediates PMA-induced signaling | Key target for differentiation and cancer studies [5, 8] |
| PRKCB | PKC beta isoform; involved in immune responses | Modulates NF-κB activation [4, 6] |
| PRKCQ | PKC theta isoform; T-cell activation | Potential target in inflammation |
| PRKCE | PKC epsilon isoform; oncogenic roles | Implicated in melanoma resistance |
| PRKCH | PKC eta isoform; proliferative response in astrocytic tumors | Studied in astrocytoma |
| FOS | AP-1 transcription factor component | PMA-responsive gene [4, 6] |
| JUN | AP-1 transcription factor component | PMA-responsive gene [4, 6] |
| NFKB1 | NF-κB subunit; regulates immune genes | PMA activates NF-κB [4, 6] |
| RELA | NF-κB subunit; regulates immune genes | PMA activates NF-κB [4, 6] |
| OSM | Oncostatin-M cytokine; induced by PMA | Regulates inflammation and growth |
| IL1B | Interleukin-1 beta; secreted upon inflammasome activation | PMA-differentiated macrophages |
| NLRP3 | Inflammasome sensor; activated in PMA-treated macrophages | Model for autoinflammatory diseases |
| TNF | Tumor necrosis factor; pro-inflammatory cytokine | PMA-induced secretion [1, 6] |
| CD14 | Monocyte/macrophage marker; upregulated by PMA | Differentiation marker [1, 6] |
| ITGAM | Integrin alpha M; macrophage marker | Differentiation marker |
| MMP9 | Matrix metalloproteinase-9; secreted by macrophages | PMA-induced |
| VIM | Vimentin; cytoskeletal protein | PMA-induced morphological changes |
How Is cellular response to phorbol 13-acetate 12-myristate Regulated?
The cellular response to PMA is tightly regulated at multiple levels. PKC activation is transient and subject to negative feedback via phosphorylation and degradation. Downstream signaling is modulated by phosphatases (e.g., PP2A) and cross-talk with other pathways such as PI3K/Akt and MAPK [6, 8]. In THP-1 macrophages, resting time after PMA treatment affects the responsiveness to subsequent stimuli, indicating that the differentiation state and timing are critical regulatory factors. Additionally, PMA-induced transcriptional programs are controlled by transcription factors like NF-κB and AP-1, which integrate signals from PKC and other kinases [4, 6].
cellular response to phorbol 13-acetate 12-myristate and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRKCA | Cancer, immune disorders | Knockout in THP-1 cells to study differentiation [1, 6] |
| PRKCH | Astrocytoma | Overexpression in astrocytic tumor cells |
| NLRP3 | Autoinflammatory diseases | Knockout in THP-1 macrophages to study inflammasome |
| OSM | Inflammation, cancer | Knockdown in PMA-treated cells to assess cytokine production |
| IL1B | Inflammatory diseases | Point mutation knock-in to modulate secretion |
Cancer
PMA is a known tumor promoter, and the cellular response to PMA is linked to cancer progression. In melanoma cells, PMA induces resistance to NK and LAK cell-mediated cytotoxicity, suggesting a mechanism of immune evasion. In astrocytic tumor cells, PMA stimulates a PKC-eta-specific proliferative response, contributing to tumor growth. These findings highlight the importance of PMA-responsive pathways in cancer biology and potential therapeutic targeting [7, 8].
Inflammatory and Autoimmune Diseases
PMA-induced differentiation of monocytes to macrophages is a model for studying inflammation. The NLRP3 inflammasome, activated in PMA-treated macrophages, plays a key role in autoinflammatory diseases. PMA also induces pro-inflammatory cytokines like TNF-α and IL-1β, which are implicated in rheumatoid arthritis and inflammatory bowel disease [1, 2, 6]. Understanding the regulation of these responses can inform anti-inflammatory therapies [2, 6].
Immune Disorders
The cellular response to PMA affects immune cell function, including T-cell activation and cytokine production. Dysregulation of PKC isoforms, which are central to PMA signaling, has been associated with autoimmune diseases and immunodeficiencies [6, 8]. Studying PMA responses in immune cells can reveal mechanisms of immune dysregulation and potential drug targets.
From cellular response to phorbol 13-acetate 12-myristate-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X mediate PMA-induced differentiation? | CRISPR knockout in THP-1 or U937 cells [1, 2] |
| Does a specific mutation in gene Y alter PMA response? | Point mutation knock-in in monocytic cell lines |
| Can overexpression of gene Z enhance PMA-induced cytokine production? | Overexpression in THP-1 cells |
| What is the role of gene W in PMA-induced PKC activation? | Knockout in astrocytic tumor cells |
| Does tagging gene V reveal its localization upon PMA treatment? | Tagged knock-in in melanoma cells |
| Can CRISPR library screening identify novel regulators of PMA response? | Genome-wide knockout library in THP-1 cells |
How to Study the cellular response to phorbol 13-acetate 12-myristate Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify PMA-responsive genes [4, 6] |
| Proteomics | Protein abundance and modifications | Discover immune modulators |
| ELISA | Cytokine secretion | Measure TNF-α, IL-1β, OSM [2, 4] |
| Flow cytometry | Surface marker expression | Assess macrophage differentiation [1, 6] |
| Cytotoxicity assay | NK/LAK cell-mediated killing | Study immune evasion |
| Western blot | Protein phosphorylation and expression | Analyze PKC activation |
| Microscopy | Cell morphology and protein localization | Monitor differentiation and PKC translocation [1, 8] |
Transcriptomics (RNA-seq)
RNA sequencing of PMA-treated cells at multiple time points reveals global changes in gene expression, including upregulation of macrophage markers and cytokines [4, 6]. This method identifies PMA-responsive genes and pathways, providing insights into the transcriptional reprogramming.
Proteomics
Mass spectrometry-based proteomics of PMA-differentiated cells quantifies changes in protein abundance and post-translational modifications, uncovering immune response modulators. Comparative proteomic analysis of THP-1 monocytes and macrophages identified proteins with varying impacts on immune responses.
Functional Assays
Cytokine secretion assays (ELISA), flow cytometry for surface markers, and cytotoxicity assays measure functional outcomes of PMA response [1, 2, 7]. For example, NK cell-mediated cytotoxicity assays assess PMA-induced resistance in melanoma cells.
Imaging and Morphology
Microscopy techniques (phase-contrast, fluorescence) monitor morphological changes such as adherence and spreading during PMA-induced differentiation [1, 3]. Live-cell imaging can track PKC translocation in real time.
How CRISPR Can Be Used to Study GO:1904628 cellular response to phorbol 13-acetate 12-myristate
Knockout
CRISPR knockout of candidate genes (e.g., PRKCA, NLRP3) in monocytic cell lines followed by PMA treatment can determine their necessity for differentiation, cytokine production, or inflammasome activation [1, 2]. This approach provides causal evidence and helps identify therapeutic targets.
Point Mutation
Introducing specific point mutations (e.g., in IL1B or PKC isoforms) via CRISPR can mimic disease-associated variants and assess their impact on PMA response. This is useful for studying functional consequences of SNPs.
Knock-in
Knock-in of tagged versions of genes (e.g., GFP-PKC) allows real-time tracking of protein localization and dynamics upon PMA stimulation. This can reveal spatiotemporal regulation of signaling.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like OSM can test sufficiency in driving PMA-like responses. Overexpression studies help establish gain-of-function effects.
How EDITGENE Supports cellular response to phorbol 13-acetate 12-myristate Research
Researchers studying cellular response to phorbol 13-acetate 12-myristate-related genes often need to determine whether a candidate gene is causally involved in differentiation, cytokine production, or immune modulation. EDITGENE provides comprehensive CRISPR-based services to create precise cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for cellular response to phorbol 13-acetate 12-myristate research.
Frequently Asked Questions About cellular response to phorbol 13-acetate 12-myristate
What is GO:1904628?
GO:1904628 is a Gene Ontology term for the cellular response to phorbol 13-acetate 12-myristate (PMA), encompassing all changes in cell state or activity triggered by PMA [1, 2].
What is phorbol 13-acetate 12-myristate?
Phorbol 13-acetate 12-myristate (PMA) is a phorbol ester and potent PKC activator used to study signal transduction and differentiation [5, 8].
What genes are involved in cellular response to PMA?
Key genes include PKC isoforms (PRKCA, PRKCB, PRKCH), transcription factors (FOS, JUN, NFKB1), and cytokines (OSM, IL1B, TNF) [4, 6, 8].
How is PMA used in cell culture?
PMA is used to differentiate monocytic cell lines like THP-1 and U937 into macrophages, and to activate PKC signaling [1, 2, 3].
What are the synonyms for GO:1904628?
Synonyms include cellular response to PMA, cellular response to TPA, and cellular response to tetradecanoylphorbol acetate.
Why is PMA important in cancer research?
PMA is a tumor promoter and induces immune evasion and proliferation in cancer cells, making it a tool to study oncogenic pathways [7, 8].
What pathways are activated by PMA?
PMA activates PKC, MAPK/ERK, NF-κB, and AP-1 pathways, leading to changes in gene expression and cell behavior [4, 6, 8].
How does PMA affect immune cells?
PMA induces differentiation of monocytes to macrophages, stimulates cytokine secretion, and activates the NLRP3 inflammasome [1, 2, 6].
What is the role of PKC in PMA response?
PKC is the primary target of PMA; binding activates PKC, which then phosphorylates downstream targets to initiate signaling [5, 8].
Can CRISPR be used to study PMA response?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise dissection of genes involved in PMA response [1, 2, 4].
Conclusion
GO:1904628 cellular response to phorbol 13-acetate 12-myristate is a fundamental biological process that underpins many experimental models in immunology and cancer research. The response involves PKC activation, transcriptional reprogramming, and functional changes such as differentiation and cytokine secretion [1, 2, 4, 6]. Understanding this process is essential for interpreting data from PMA-treated cells and for developing therapeutic strategies targeting related pathways [7, 8]. With CRISPR-based tools from EDITGENE, researchers can precisely manipulate genes to uncover causal mechanisms and accelerate discovery.
References
- 1. Lund ME et al.. 2016. The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus.. J Immunol Methods 430:64-70 PMID: 26826276
- 2. Giambelluca S et al.. 2022. Resting time after phorbol 12-myristate 13-acetate in THP-1 derived macrophages provides a non-biased model for the study of NLRP3 inflammasome.. Front Immunol 13:958098 PMID: 36618426
- 3. Valdés López JF et al.. 2018. Synergism between phorbol-12-myristate-13-acetate and vitamin D3 in the differentiation of U937 cells to monocytes and macrophages.. Morphologie 102(338):205-218 PMID: 30075941
- 4. Mukherjee S et al.. 2016. Phorbol-12-myristate-13-acetate (PMA) mediated transcriptional regulation of Oncostatin-M.. Cytokine 88:209-213 PMID: 27676154
- 5. Schimmel SD et al.. 1980. Binding of phorbol-12-myristate-13-acetate to cultured myoblasts.. Cancer Lett 9(3):229-36 PMID: 7226155
- 6. Pinto SM et al.. 2021. Comparative Proteomic Analysis Reveals Varying Impact on Immune Responses in Phorbol 12-Myristate-13-Acetate-Mediated THP-1 Monocyte-to-Macrophage Differentiation.. Front Immunol 12:679458 PMID: 34234780
- 7. Correale P et al.. 1992. Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity.. Cancer Immunol Immunother 34(4):272-8 PMID: 1371427
- 8. Hussaini IM et al.. 2000. Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific proliferative response in astrocytic tumor cells.. J Biol Chem 275(29):22348-54 PMID: 10806212
